BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc.（BCRX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · BCRX · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
10
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
BioCryst Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
BCRX 季度内部人买卖趋势
BCRX 内幕交易卖出 · BCRX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · BCRX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
BCRX 高管卖出股份 · BCRX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 29, 2026 | Milne Jill C. Director | Award | 1,262 | $11K | Form 4 |
| May 29, 2026 | Stonehouse Jon P Director | Award | 631 | $6K | Form 4 |
| May 29, 2026 | McKee Amy E Director | Award | 631 | $6K | Form 4 |
| May 29, 2026 | MILANO VINCENT Director | Award | 1,122 | $10K | Form 4 |
| May 29, 2026 | Frank Steven Director | Award | 1,262 | $11K | Form 4 |
| May 18, 2026 | McKee Amy E Director | Sale | 11,180 | $100K | Form 4 |
| May 13, 2026 | Barnes Alane P Chief Legal Officer | Option | 62,500 | $315K | Form 4 |
| May 13, 2026 | Barnes Alane P Chief Legal Officer | Sale | 62,500 | $596K | Form 4 |
| Apr 6, 2026 | Menon Sandeep Chief R&D Officer | Award | 205,150 | — | Form 4 |
| Mar 20, 2026 | HEGGIE THERESA Director | Option | 49,933 | $315K | Form 4 |
| Mar 20, 2026 | HEGGIE THERESA Director | Sale | 49,933 | $505K | Form 4 |
| Mar 16, 2026 | Barnes Alane P Chief Legal Officer | Option | 150,000 | $827K | Form 4 |
| Mar 16, 2026 | Barnes Alane P Chief Legal Officer | Sale | 150,000 | $1.37M⚡ | Form 4 |
| Feb 27, 2026 | Milne Jill C. Director | Award | 528 | $5K | Form 4 |
| Mar 2, 2026 | Stonehouse Jon P Director | Option | 305,995 | $985K | Form 4 |
| Feb 27, 2026 | Stonehouse Jon P Director | Award | 421 | $4K | Form 4 |
| Mar 2, 2026 | Stonehouse Jon P Director | Other | 305,995 | $2.64M⚡ | Form 4 |
| Feb 27, 2026 | MILANO VINCENT Director | Award | 848 | $7K | Form 4 |
| Feb 27, 2026 | Frank Steven Director | Award | 1,285 | $11K | Form 4 |
| Feb 27, 2026 | McKee Amy E Director | Award | 642 | $6K | Form 4 |
| Jan 23, 2026 | Milne Jill C. Director | Award | 12,272 | — | Form 4 |
| Jan 23, 2026 | Milne Jill C. Director | Award | 2,582 | $22K | Form 4 |
| Dec 19, 2025 | Stonehouse Jon P CEO · Director | Other | 61,793 | $458K | Form 4 |
| Dec 19, 2025 | Barnes Alane P Chief Legal Officer | Other | 16,902 | $125K | Form 4 |
| Dec 22, 2025 | Barnes Alane P Chief Legal Officer | Sale | 21,773 | $167K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 BCRX 内幕交易
BCRX 内幕交易
BioCryst Pharmaceuticals, Inc.（BCRX）内幕交易数据来源于公司内部人（包括Barnes Alane P (Chief Legal Officer), Stonehouse Jon P (Director), McKee Amy E (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。BCRX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看BioCryst Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
BCRX 内幕交易 · 5个问题BioCryst Pharmaceuticals, Inc.（BCRX）的内部人包括高管和董事，如Barnes Alane P (Chief Legal Officer), Stonehouse Jon P (Director), McKee Amy E (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026